Immunotherapy of patients with hormone-refractory prostate carcinoma pre-treated with interferon-gamma and vaccinated with autologous PSA-peptide loaded dendritic cells--a pilot study. [electronic resource]
Producer: 20070503Description: 500-8 p. digitalISSN:- 0270-4137
- Aged
- Aged, 80 and over
- Cancer Vaccines -- adverse effects
- Dendritic Cells -- immunology
- Disease Progression
- HLA-A2 Antigen -- immunology
- Humans
- Immunotherapy, Adoptive -- adverse effects
- Injections, Subcutaneous
- Interferon-gamma -- adverse effects
- Male
- Middle Aged
- Pilot Projects
- Prostate-Specific Antigen -- immunology
- Prostatic Neoplasms -- immunology
- Quality of Life
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.